Aisling Capital Management LP Avrobio, Inc. Transaction History
Aisling Capital Management LP
- $292 Million
- Q1 2024
A detailed history of Aisling Capital Management LP transactions in Avrobio, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 1,009,779 shares of AVRO stock, worth $1.49 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
1,009,779
Previous 1,009,779
-0.0%
Holding current value
$1.49 Million
Previous $1.37 Million
5.9%
% of portfolio
0.44%
Previous 0.41%
Shares
4 transactions
Others Institutions Holding AVRO
# of Institutions
49Shares Held
28.1MCall Options Held
9KPut Options Held
100-
Atlas Venture Life Science Advisors, LLC4.54MShares$6.72 Million0.73% of portfolio
-
Bml Capital Management, LLC Zionsville, IN4MShares$5.92 Million3.43% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.95MShares$5.85 Million1.15% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.93MShares$2.85 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$2.78 Million0.0% of portfolio
About AVROBIO, Inc.
- Ticker AVRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,773,900
- Market Cap $64.8M
- Description
- AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...